Skip to main content

Advertisement

Table 2 Changes of drug sensitivity in 88 treatment-failure HIV/AIDS cases

From: Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China

Drugs/Frequency Grade of DR(N/%)
Susceptible Potential resistance Low-level resistance Intermediate resistance High-level resistance
3TC
 T1 72 (81.82) 16 (18.18)
 T2 70 (79.55) 18 (20.45)
 T3 69 (78.41) 1 (1.14) 18 (20.45)
AZT
 T1 83 (94.32) 1 (1.14) 1 (1.14) 3 (3.41)
 T2 77 (87.50) 3 (3.41) 1 (1.14) 4 (4.55) 3 (3.41)
 T3 75 (85.23) 4 (4.55) 2 (2.27) 2 (2.27) 5 (5.68)
D4T
 T1 82 (93.18) 2 (2.27) 1 (1.14) 3 (3.41)
 T2 75 (85.23) 3 (3.41) 3 (3.41) 4 (4.55) 3 (3.41)
 T3 72 (81.82) 4 (4.55) 3 (3.41) 3 (3.41) 6 (6.82)
TDF
 T1 81 (92.05) 3 (3.41) 1 (1.14) 3 (3.41)
 T2 82 (93.18) 2 (2.27) 1 (1.14) 3 (3.41)
 T3 78 (88.64) 5 (5.68) 2 (2.27) 3 (3.41)
EFV
 T1 51 (57.95) 6 (6.82) 3 (3.41) 8 (9.09) 20 (22.73)
 T2 50 (56.82) 6 (6.82) 2 (2.27) 9 (10.23) 21 (23.86)
 T3 52 (59.09) 6 (6.82) 1 (1.14) 7 (7.95) 22 (25.00)
ETR
 T1 61 (69.32) 13 (14.77) 6 (6.82) 7 (7.95) 1 (1.14)
 T2 58 (65.91) 11 (12.50) 5 (5.68) 10 (11.36) 4 (4.55)
 T3 57 (64.77) 13 (14.77) 4 (4.55) 9 (10.23) 5 (5.68)
NVP
 T1 53 (60.23) 5 (5.68) 1 (1.14) 2 (2.27) 27 (30.68)
 T2 51 (57.95) 5 (5.68) 1 (1.14) 2 (2.27) 29 (32.95)
 T3 51 (57.95) 6 (6.82) 1 (1.14) 1 (1.14) 29 (32.95)
LPV/r
 T1 87 (98.86) 1 (1.14)
 T2 85 (96.59) 1 (1.14) 2 (2.27)
 T3 84 (95.45) 1 (1.14) 2 (2.27)
  1. T1: First detection, T2, T3 and the like